[Federal Register Volume 68, Number 150 (Tuesday, August 5, 2003)]
[Notices]
[Page 46225]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-19811]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated March 21, 2003, and published in the Federal 
Register on April 9, 2003, (68 FR 17402), Boehringer Ingelheim 
Chemicals, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, 
made application by renewal to the Drug Enforcement Administration to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances sited below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Methadone (9250)...........................  II
Methadone-intermediate (9254)..............  II
Dextropropoxyphene, bulk (non-dosage forms)  II
 (9273).
Levo-alphacetylmethadol (9648).............  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances for 
formulation into finished pharmaceuticals.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Boehringer Ingelheim Chemicals, 
Inc. to manufacture the listed controlled substances is consistent with 
the public interest at this time. DEA has investigated Boehringer 
Ingelheim Chemicals, Inc. to ensure that the company's registration is 
consistent with the public interest. This investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control, hereby orders that the 
application submitted by the above firm for registration as a bulk 
manufacturer of the basic classes of controlled substances listed above 
is granted.

    Dated: July 22, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-19811 Filed 8-4-03; 8:45 am]
BILLING CODE 4410-09-M